Search

Stryker Corp

Closed

SectorHealthcare

273.92 -2.02

Overview

Share price change

24h

Current

Min

273.92

Max

276.83

Key metrics

By Trading Economics

Income

531M

1.3B

Sales

569M

6.6B

P/E

Sector Avg

29.24

56.432

EPS

3.69

Dividend yield

1.26

Profit margin

19.366

Employees

56,000

EBITDA

266M

1.6B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+34.94% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.26%

2.27%

Next Earnings

29 paź 2026

Next Dividend date

30 paź 2026

Next Ex Dividend date

29 wrz 2026

Market Stats

By TradingEconomics

Market Cap

-21B

108B

Previous open

275.94

Previous close

273.92

News Sentiment

By Acuity

56%

44%

262 / 339 Ranking in Healthcare

Stryker Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 wrz 2026, 23:02 UTC

Stryker Corp is seeing a notable increase in after-market trading, gaining ground since Friday's close and reflecting significant upward movement.

17 wrz 2026, 20:07 UTC

News

Stryker Corporation's stock fell amid scrutiny over ongoing manufacturing issues, resulting in a loss of over $10 billion in market capitalization.

16 wrz 2026, 23:01 UTC

Correlated Moves

Stryker Corp is experiencing a modest decline in after-market trading, retracing significantly after peaking post-close amid broader market fluctuations.

15 wrz 2026, 23:21 UTC

Stryker Corp shares are lower in after-market hours, reflecting broader market trends as rising Treasury yields pressure equities amid rate hike expectations.

14 wrz 2026, 20:03 UTC

News

Stryker Corp shares are higher today, responding positively despite Citigroup lowering its price target to $360 while maintaining a "buy" rating.

11 wrz 2026, 22:01 UTC

Stryker Corp shares are lower in after-market trading. The decline follows a drop in the Michigan Consumer Sentiment Index, reflecting consumer concerns about inflation.

10 wrz 2026, 20:03 UTC

Macro Event
News

Stryker Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in share price amid ongoing manufacturing issues.

9 wrz 2026, 20:07 UTC

News

Stryker Corp shares are declining amid a securities fraud investigation and a lowered price target of $348 from Wells Fargo.

8 wrz 2026, 23:06 UTC

Stryker Corp. shares are higher in after-market trading, following seven consecutive sessions of declines amid rising expectations for a Federal Reserve interest rate hike.

4 wrz 2026, 20:07 UTC

Stryker Corp shares are lower today, marking six consecutive sessions of declines. The stock remains significantly below its 20-day moving average.

3 wrz 2026, 19:36 UTC

Stryker Corp shares are lower today, continuing a four-session decline. The stock remains significantly below its 20-day moving average amid broader market trends.

2 wrz 2026, 22:16 UTC

Shares of Stryker Corp are trading higher in after-market hours, following a session peak. Broader market concerns include rising oil prices and inflation risks.

1 wrz 2026, 23:26 UTC

Stryker Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. Rising oil prices are noted as broader market context.

31 sie 2026, 20:03 UTC

Stryker Corp shares are lower amid broader market pressures from Jackson Hole remarks on inflation and potential interest rate hikes. No specific company news identified.

28 sie 2026, 20:02 UTC

Stryker Corp shares are higher today, continuing an upward trend since Thursday's close, despite earlier session declines. No specific news was identified.

27 sie 2026, 21:02 UTC

Correlated Moves

Shares rise in after-market hours, rebounding from three lower sessions.

26 sie 2026, 20:08 UTC

Stryker Corp shares are lower as inflation data shows consumer prices rose more than expected, influencing broader market trends. No specific company news was identified.

25 sie 2026, 23:36 UTC

Stryker Corp shares are lower in after-market trading, positioned below their 20-day moving average and near the lower end of their one-month range.

24 sie 2026, 20:06 UTC

News

Stryker Corp received a $100 million contract modification from the U.S. Department of Defense, but shares are trading lower amid rising oil prices and geopolitical tensions.

21 sie 2026, 19:53 UTC

News

Stryker Corp shares are higher as insider selling by Ronda E. Stryker is offset by strong financial metrics, including a 9.42% revenue growth rate.

20 sie 2026, 20:02 UTC

News

Stryker Corp shares are lower today, reflecting broader market pressures following Walmart's disappointing earnings and a 3.40% decline since Wednesday.

19 sie 2026, 20:02 UTC

News

Stryker Corp received a $100 million contract modification from the Defense Logistics Agency, boosting shares during Wednesday's trading session.

18 sie 2026, 19:35 UTC

Stryker Corp is advancing today, driven by gains in the Health Care Equipment sub-sector. Earlier, shares peaked before pulling back slightly.

17 sie 2026, 19:51 UTC

Stryker Corp shares are lower today, continuing a decline influenced by weakness in the Health Care Equipment sector. No specific news was identified.

14 sie 2026, 19:56 UTC

Stryker Corp shares are lower amid broader market sentiment following a surprise drop in U.S. retail sales for July. The stock has seen lower closes recently.

13 sie 2026, 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

12 sie 2026, 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

11 sie 2026, 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

10 sie 2026, 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

7 sie 2026, 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

34.94% upside

12 Months Forecast

Average 371.235 USD  34.94%

High 420 USD

Low 317 USD

Based on 18 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

18 ratings

16

Buy

2

Hold

0

Sell

Sentiment

By Acuity

262 / 339 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.